Arnold Palmer Hospital for Children Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01294670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Arnold Palmer Pediatric Endocrinology Practice, Orlando, Florida

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 2)

Puberty, Precocious (Phase 3)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6